Clinical Trials on Nonseminomatous Germ Cell Tumor in Switzerland
Total 336 results
-
University of Lausanne HospitalsLionel Perrier Foundation (Montreux, Switzerland)Completed
-
NovartisCompletedMetastatic MelanomaSwitzerland
-
Reinhard DummerCompleted
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
University Hospital, Basel, SwitzerlandCompletedGlioblastomaSwitzerland
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
PIQUR Therapeutics AGUniversity Hospital Inselspital, Berne; University Hospital, Basel, Switzerland and other collaboratorsTerminatedGlioblastoma MultiformeSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Andreas HottingerEcole Polytechnique Fédérale de LausanneUnknownGlioblastomaSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital Inselspital, Berne; Luzerner Kantonsspital; University Hospital...TerminatedNeoplasms | GlioblastomaSwitzerland
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsSwitzerland
-
Ente Ospedaliero Cantonale, BellinzonaNeurocenter of Southern Switzerland; Istituto Cantonale di PatologiaRecruiting
-
University of ZurichRecruitingGlioblastoma MultiformeSwitzerland
-
University of ZurichUnknownGlioblastomaSwitzerland
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
University Hospital Inselspital, BerneCompletedNeuroendocrine Tumors of the AppendixSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Basel, Department of Sport, Exercise and Health, Division of Sport...Completed
-
Philogen S.p.A.Completed
-
University of ZurichSwiss National Science FoundationRecruiting
-
Centre Hospitalier Universitaire VaudoisRecruitingMetastasis From Malignant Melanoma of Skin (Diagnosis)Switzerland
-
University of ZurichMerck Sharp & Dohme LLCActive, not recruiting
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ZurichTerminated
-
Novartis PharmaceuticalsCompletedPigmented Villonodular Synovitis | PVNS | Giant Cell Tumor of the Tendon Sheath | GCCTS | Tenosynovial Giant Cell Tumor Localized or Diffused Type | GCTSUnited States, Switzerland
-
Insel Gruppe AG, University Hospital BernRecruitingGlioblastoma | Dexamethasone | SteroidsSwitzerland
-
Mundipharma Research LimitedActive, not recruitingGlioblastoma MultiformeSwitzerland, Spain
-
University Hospital, GenevaActive, not recruitingGlioblastoma Multiforme | Glioblastoma Multiforme of Brain | Glioma of Brain | Glioblastoma, AdultSwitzerland
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
University Hospital, GenevaBayerCompletedGlioblastoma | Gliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic OligodendrogliomaSwitzerland
-
University of ZurichCompletedRecurrent GlioblastomaSwitzerland
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
University of BirminghamRoche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.Active, not recruitingNeuroblastomaFrance, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
-
Institut CurieServier; UNICANCERCompletedUveal MelanomaFrance, Switzerland
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
Hoffmann-La RocheCompletedMalignant MelanomaSwitzerland
-
Immatics Biotechnologies GmbHBioNTech SE; University Hospital Tuebingen; BCN Peptides; EU-funded GAPVAC ConsortiumCompletedGlioblastomaSpain, Switzerland, Denmark, Germany, Netherlands
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Organisation for Research and Treatment...UnknownBrain and Central Nervous System TumorsSwitzerland, France
-
Incyte CorporationActive, not recruitingMetastatic Merkel Cell CarcinomaUnited Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Basilea PharmaceuticaCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Switzerland, Netherlands, New Zealand
-
European Infant Neuroblastoma Study Group - 1999CompletedCombination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.NeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia GroupCompletedNeuroblastomaSwitzerland, Spain, Germany, Belgium, France, Denmark, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsSwitzerland, Italy, Belgium, Germany, Netherlands
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain